Pharmaceuticals

“Generic drug-making is a fast-track business”: Sandoz trademark head reveals approach to IP management

In a wide-ranging interview, INTA’s president-elect and global head of trademarks for Sandoz, David Lossignol, talks about the challenges of managing pharmaceutical brand rights and the growing threat of IP restrictions.

Read more

Constitutional Court softens country's stance on parallel imports

The Constitutional Court has confirmed that the principle of national exhaustion of trademark rights is constitutional, but has increased the burden of proof imposed on trademark owners in parallel importation cases.

Read more

Good news for rights holders: SON and NAFDAC enter into partnership to tackle fake and substandard products

The Standard Organisation of Nigeria and the National Agency for Food and Drugs Administration and Control have entered into a partnership to tackle and combat fake and substandard products in the country.

Read more

Tough blow for Novartis: General Court confirms that mark representing transdermal patch is invalid

The General Court has upheld a decision of the EUIPO finding that Novartis’ figurative EU trademark, which represents the company’s Exolon transdermal patch, was invalid.

Read more

Confusion with internationalised domain names

A UDRP panel has denied the transfer of the ‘physiothérapie.com’ domain name in a decision that emphasises the importance of proving bad faith.

Read more

WTR Industry Awards 2018: the shortlist revealed

The WTR Industry Awards 2018 honour leading trademark teams and individuals across a range of sectors. We reveal the shortlist.

Read more

WIPO reveals strong growth in Madrid applications; L’Oreal, Novartis and Abercrombie feature in top filers list

​​​​​​​WIPO has released filing statistics on the Madrid System for trademarks, revealing growth for international marks, with those originating in China, Russia and the United Kingdom showing significant rises...

Read more

Latest edition of Pharmaceutical Trademarks: A Global Guide now available

The seventh edition of Pharmaceutical Trademarks: A Global Guide, which provides trademark professionals with comprehensive guidance on the key issues involved in the protection, enforcement and marketing of pharmaceutical brands, is now available...

Read more

Pharma brands warned not to be ‘trademark bullies’, Turkey on top, and world’s oldest mark: news round-up

We look at Turkey moving to the top of the European trademark filing league, Activision prevailing in a lawsuit in China, and a warning to pharma brands.

Read more

Procedures and strategies for pharmaceutical brands: Chile

Two frameworks are applicable to pharmaceutical marks in Chile. The Industrial Property Law and its regulation set out the rules for the registration and use of trademarks; the Sanitary Code and Decree 3/2010 regulate the pharmaceutical product marketing authorisation...

Read more

Procedures and strategies for pharmaceutical brands: Canada

Sweeping amendments to the Trademarks Act are expected to be implemented in 2019. The amendments will fundamentally affect the way in which all trademark owners will need to approach their selection, clearance and registration strategies, and the pharmaceutical...

Read more

Procedures and strategies for pharmaceutical brands: Brazil

Brazil is a first-to-file jurisdiction, and therefore IP rights are acquired only when an application is filed and registered with the Brazilian Patent and Trademark Office. However, pharmaceutical trademarks fall under two separate and independent statutory regimes...

Read more

Procedures and strategies for pharmaceutical brands: France

In order for a pharmaceutical trademark to be registered, no prior authorisation is needed per se. Unlike in other countries, in France the trademark owner is independent from the party exploiting the trademark and need not possess a particular quality.

Read more

Healthcare market robust – brands prosper while Chinese filings dominate: exclusive data analysis

In our latest industry data report, we explore the thriving and evolving healthcare industry. Our in-depth analysis reveals the trends driving this evolution, while also analysing key trademark filing statistics in this space...

Read more

Big changes in the pharmaceutical sector as leading brands flourish

A deep dive into key data about the pharmaceuticals sector suggests that over-regulation and availability of skills and technology remain key challenges; while the leading brands continue to rise in value, most are still filing in single classes only.

Read more

Big changes in the pharmaceutical sector as leading brands flourish: exclusive data analysis

In this week’s data report, we turn the spotlight on the sprawling pharmaceutical sector. We look at how the sector is being affected by political pressures, and identify the developments that are driving change.

Read more
Close

Register for more free content

  • Read more World Trademark Review blogs and articles
  • Receive the editor's weekly review by email
Register now  
Issue 72